|
Experiment Number
|
Experiment Title
|
Investigator
|
Target Mission (if known)
|
|
96-01-057 DSO 633
|
Renal Stone Risk During Space Flight: Assessment and Countermeasure Validation
|
P.A. Whitson
|
Incr. 3-10 (7A.1), STS-107, STS-113, R-2
|
|
SMO 008
|
Entry Monitoring
|
Meck
|
Incr. 8
|
|
SMO 006
|
Test of Midodrine as Countermeasure against Postflight Orthostatic Hypotension
|
Meck
|
Incr. 5, STS-108, 110, 111, 112, 109
|
|
NASA-Sponsored ISS Flight Monitoring
|
|
MR085L
|
Neurocognitive Assessment (SCAT)
|
|
All
|
|
MR077L
|
Physical Fitness Assessment
|
All
|
|
MR021L
|
Crew Microbiology
|
All
|
|
MR016L
|
Inflight weekly food frequency questionnaire
|
All
|
|
MR024L
|
Body Mass Measurement
|
All
|
|
MR018L
|
Inflight urinalysis/hematocrit
|
All
|
|
MR003L
|
Radiation Biodosimetry
|
All
|
|
NASA-Sponsored ISS Pre/Post Flight Testing
|
|
MR035L
|
Bone Densitometry
|
|
All
|
|
MR001L
|
Operational Tilt Test
|
All
|
|
MR071L
|
Holter Monitoring
|
All
|
|
MR010L
|
Clinical Laboratory Assessment
|
All
|
|
MR077L
|
Isokinetic Dynamometry/FASTEX
|
All
|
|
MR042L
|
Functional Neurological Assessment
|
All
|
|
Russian Flight Experiments
|
|
MBI-1
|
Study of human body fluids under conditions of long-duration spaceflight
|
|
|
MBI-3
|
Study of peridontal tissue conditions under spaceflight conditions
|
|
MBI-4
|
Study of pharmacological influences under long-duration space mission conditions
|
|
MBI-5
|
Intergrated study of the dynamics of the primary parameters of cardiac activity and blood circulation, using a lower body negative pressure (LBNP) apparatus
|
|
MBI-8
|
Study of the action mechanism and efficacy of various countermeasures aimed at preventing locomotion system disorders in weightlessness
|
|
MBI-9
|
Study of autonomic regulation of the human cardiovascular system in weightlessness
|
|
RBO-1
|
Development of a method for real-time prediction of dose loads on the crews of manned space missions
|
